Related Experiment Video

Updated: Jul 10, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Control of osteoclast activity and bone loss by IKK subunits: new targets for therapy

Maria Grazia Ruocco1, Michael Karin

  • 1Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.

Advances in Experimental Medicine and Biology
|October 31, 2007
PubMed

Insights

The study reveals that IKKbeta, not IKKalpha, is crucial for osteoclastogenesis and bone loss. Inhibiting IKKbeta offers a promising therapeutic strategy for inflammatory bone resorption.

Area of Science:

  • Molecular Biology
  • Immunology
  • Bone Biology

Background:

  • Nuclear factor-kappaB (NF-kappaB) is a key regulator of osteoclastogenesis and bone loss associated with inflammation.
  • Receptor activator of NF-kappaB (RANK) signaling pathway plays a critical role in these processes.

Purpose of the Study:

  • To investigate the specific roles of IKKalpha and IKKbeta in mediating RANK signals to NF-kappaB.
  • To evaluate the therapeutic potential of targeting IKKbeta in inflammation-induced bone loss.

Main Methods:

  • Utilized a genetic approach in mice to ablate IKKbeta.
  • Assessed osteoclastogenesis and response to inflammation-induced bone loss in IKKbeta-deficient mice.

Main Results:

  • Ablation of IKKbeta completely inhibited osteoclastogenesis.
  • IKKbeta-deficient mice showed no bone loss in response to inflammatory stimuli.
  • IKKbeta, not IKKalpha, was identified as the critical transducer of RANK to NF-kappaB signaling.

Conclusions:

  • IKKbeta is essential for osteoclast formation and mediating bone loss during inflammation.
  • Targeting IKKbeta presents a viable therapeutic strategy for inflammatory bone resorption, offering an alternative to current treatments.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...